OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Chao Liu, Zhaoying Yao, Jianing Wang, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 6, pp. 1765-1781
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 302

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Jan Korbecki, Szymon Grochans, Izabela Gutowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7619-7619
Open Access | Times Cited: 276

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Chunxiao Li, Xiaofei Xu, Shuhua Wei, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001341-e001341
Open Access | Times Cited: 214

Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001895-e001895
Open Access | Times Cited: 167

Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
Shujing Wang, Jingrui Wang, Zhiqiang Chen, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 140

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 99

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65

Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
Philip Schmassmann, Julien Roux, Alicia Buck, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Closed Access | Times Cited: 44

Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 26

The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
Mingyang Liu, Yu Ren, Zhijun Zhou, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 885-903.e4
Open Access | Times Cited: 21

The effects of metabolism on the immune microenvironment in colorectal cancer
Xingzhao Chen, Zhiyuan Ma, Zhiqiang Yi, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 20

Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
Dan Zhu, Ruidan Xu, Xinping Huang, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 6, pp. 1773-1789
Open Access | Times Cited: 123

Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein, Nofar Erlichman, Adit Ben‐Baruch
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 114

Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy
Xiaoli Hu, Jing Wang, Man Chu, et al.
Molecular Therapy (2021) Vol. 29, Iss. 3, pp. 908-919
Open Access | Times Cited: 98

Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
Hao Cai, Yichi Zhang, Jian Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91

The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
Yu Wang, Qingguo Sun, Ning Mu, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 89

Research trends in pharmacological modulation of tumor‐associated macrophages
Neng Wang, Shengqi Wang, Xuan Wang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 87

NF-κB and Its Role in Checkpoint Control
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 73

Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment
Chen Han, Cong Zhang, Hengxiao Wang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 73

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5647-5647
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top